RT Journal Article
SR Electronic
T1 SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006055
DO 10.1136/jitc-2022-006055
VO 11
IS 2
A1 Zhao, Jun
A1 Yu, Xinmin
A1 Huang, Dingzhi
A1 Ma, Zhiyong
A1 Gao, Bo
A1 Cui, Jiuwei
A1 Chu, Qian
A1 Zhou, Qing
A1 Sun, Meili
A1 Day, Daphne
A1 Wu, Jingxun
A1 Pan, Hongming
A1 Wang, Lifeng
A1 Voskoboynik, Mark
A1 Wang, Zhehai
A1 Liu, Yunpeng
A1 Li, Hui
A1 Zhang, Juan
A1 Peng, Yanyan
A1 Wu, Yi-Long
YR 2023
UL http://jitc.bmj.com/content/11/2/e006055.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.